Determining Allosteric Modulator Mechanism of Action: Integration of Radioligand Binding and Functional Assay Data
The drive to produce safer and more receptor subtype selective drugs has sparked a renewed interest in allosteric modulators of G protein-coupled receptors. The increasing use of functional assays has shown that allosteric ligands are capable of modulating both orthosteric agonist affinity and efficacy, as well as mediating receptor activation in their own right. Such a complex range of behaviours can be difficult to discern from single datasets; this chapter seeks to explain how to use radioligand binding and functional assay datasets in concert to elucidate allosteric modulator mechanism of action.
Key wordsAllosteric Orthosteric Binding Affinity Efficacy Potency
- 11.Fatkenheuer, G., Pozniak, A. L., Johnson, M. A., Plettenberg, A., Staszewski, S., Hoepelman, A. I., Saag, M. S., Goebel, F. D., Rockstroh, J. K., Dezube, B. J., Jenkins, T. M., Medhurst, C., Sullivan, J. F., Ridgway, C., Abel, S., James, I. T., Youle, M., and van der Ryst, E. (2005) Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1, Nat Med 11, 1170–1172.PubMedCrossRefGoogle Scholar
- 13.Motulsky, H. and Christopoulos, A. (2003) Fitting Models to Biological Data using Linear and Nonlinear Regression. A practical guide to curve fitting, GraphPad Software Inc., San Diego, CA.Google Scholar
- 19.Bennett, K. A., Langmead, C. J., Wise, A., and Milligan, G. (2009) Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein Galpha(o1) by the Ghrelin receptor, Mol Pharmacol 76, 802–811.PubMedCrossRefGoogle Scholar